Sec. 491.055. CONTRACT WITH LEAD INSTITUTION. (a) As soon as practicable after selecting a consortium to conduct ibogaine drug development clinical trials under Section 491.054 , the commission shall enter into an interagency contract, as provided by Chapter 771 , Government Code, with the lead institution of higher education of the selected consortium to provide funding to implement the consortium's proposed ibogaine drug development clinical trials. (b) The interagency contract described by Subsection (a) must specify: (1) the goals and objectives of the proposed ibogaine drug development clinical trials; (2) the proposed budget; (3) the timeline for completing the proposed objectives; (4) the for-profit, nonprofit, or public benefit corporate entities collaborating with the consortium in the drug development clinical trials under this subchapter; (5) the percentage of the revenue arising from the drug development clinical trials to be paid to the state; and (6) any other information required by the commission. (c) As soon as practicable after entering into an interagency contract under Subsection (a), the commission shall report the existence of the contract to the legislature. (d) The commission may not disburse funds to or for a selected consortium under the interagency contract described by Subsection (a) until the consortium receives and the commission verifies the receipt of matching funds from sources other than the state.
‹ Prev All Texas sections Next ›
Lexace provides legal information, not legal advice, and no attorney–client relationship is created. Statute text is provided for general information and may not reflect the most recent amendments; verify against the official state code.